Streptomyces nodosus Details: NCBI 40318, gram-negative or unknown [species]

  1. Nephrotoxicity: Amphotericin B can cause kidney damage, particularly when administered in high doses or over a prolonged period. This can manifest as increased serum creatinine levels, electrolyte imbalances, and decreased kidney function.

  2. Hepatotoxicity: In rare cases, amphotericin B may cause liver damage, leading to elevated liver enzymes and liver function abnormalities.

  3. Infusion-related reactions: During intravenous administration of amphotericin B, patients may experience infusion-related reactions such as fever, chills, nausea, vomiting, headache, and muscle or joint pain.

  4. Electrolyte disturbances: Amphotericin B can cause disturbances in electrolyte levels, particularly potassium and magnesium, which may lead to abnormalities such as hypokalemia and hypomagnesemia.

  5. Hematologic effects: Rarely, amphotericin B may cause bone marrow suppression, resulting in decreased white blood cell, red blood cell, and platelet counts.

  6. Cardiac effects: Amphotericin B may rarely cause cardiac arrhythmias, particularly in patients with underlying cardiac conditions.

  7. Allergic reactions: Some individuals may experience allergic reactions to amphotericin B, ranging from mild rashes to severe anaphylaxis.

Visuals of Interactions with other bacteria of the same rank

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Streptomyces nodosus

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.18 1 6 0 7 3.3 3 2.1 1 6 0 %ile 100 %ile
thorne 6.9 3 6 0 9 4.5 4 2.1 3 6 25 %ile 50 %ile

External Reference Ranges for Streptomyces nodosus

Streptomyces nodosus (NCBI 40318) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 0 0.62 0 0.0001
PrecisionBiome 1.1662043107207865E-05 1.1662043107207865E-05 0 0
Statistic by Lab Source for Streptomyces nodosus
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
Thorne 1.792 %   0 %  0 % 5.0 279

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions — Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

🧙? Search Hints:
General Substance Specific Substance Effect
Antibiotics, Antivirals etc linezolid (antibiotic) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high-fat diets 1 Studies recorded. The consensus is Decreases📓, Click for details.
Herb or Spice Larrea tridentata {Chaparral} 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prescription - Other metformin (prescription) 1 Studies recorded. The consensus is Increases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]